Microbiology-driven De-escalation
Microbiology-Driven De-Escalation is a clinical decision-making strategy in antimicrobial stewardship wherein the refinement of empirical therapy is specifically guided by definitive microbiological evidence, such as pathogen identification and antimicrobial susceptibility testing, to narrow spectrum, optimize efficacy, and minimize resistance selection pressure.
5
Publications
212
Citations
27
Authors
18
Institutions
Publications per year
2017–2026
1
5
Peggy L. Carver, Shu‐Wen Lin, Daryl D. DePestel et al. · Journal of Clinical Microbiology · 2008 · 56 citations · Full text
Ching‐Chi Lee, Nan–Yao Lee, Po‐Lin Chen et al. · Diagnostic Microbiology and Infectious Disease · 2015 · 38 citations
Linda Johnson, D. Patel, E. A. King et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2016 · 33 citations
Ching‐Chi Lee, Jiun‐Ling Wang, Chung-Hsun Lee et al. · International Journal of Antimicrobial Agents · 2017 · 22 citations
1–5 of 5
27
2
h-index
2
h-index
2
h-index
1
h-index
1
h-index
1–5 of 27
18
National Cheng Kung University Hospital
Tainan City, Taiwan
2 h-index
13 publications
398 citations
National Cheng Kung University
Tainan City, Taiwan
2 h-index
8 publications
208 citations
Imperial College Healthcare NHS Trust
London, United Kingdom
1 h-index
2 publications
126 citations
University of Michigan
Ann Arbor, United States
1 h-index
1 publications
56 citations
Overlook Medical Center
Summit, United States
1 h-index
1 publications
33 citations
University Health System
San Antonio, United States
1 h-index
2 publications
112 citations
Hammersmith Hospital
London, United Kingdom
1 h-index
2 publications
126 citations
Morristown Medical Center
Morristown, United States
1 h-index
2 publications
66 citations
1–8 of 18
1 publications · 33 citations
1
h-index
1 publications · 63 citations
1
h-index
1 publications · 22 citations
1
h-index
JCM · 1 publications · 56 citations
1
h-index
1 publications · 38 citations
1
h-index
1–5